Metropolitan Life Insurance Company (MetLife)’s Infinera Corporation Common Stock INFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,108
Closed -$54.9K 2215
2024
Q1
$54.9K Sell
9,108
-598
-6% -$3K ﹤0.01% 1355
2023
Q4
$46.1K Sell
9,706
-1,469
-13% -$5.78K ﹤0.01% 1492
2023
Q3
$46.7K Buy
11,175
+736
+7% +$3.18K ﹤0.01% 1437
2023
Q2
$50.4K Hold
10,439
﹤0.01% 1408
2023
Q1
$81K Sell
10,439
-1,044
-9% -$7.59K ﹤0.01% 1116
2022
Q4
$77.4K Hold
11,483
﹤0.01% 1209
2022
Q3
$55.6K Buy
11,483
+2,073
+22% +$11.4K ﹤0.01% 1397
2022
Q2
$50.4K Sell
9,410
-2,085
-18% -$13.3K ﹤0.01% 1507
2022
Q1
$99.7K Sell
11,495
-29,767
-72% -$256K ﹤0.01% 1196
2021
Q4
$396K Sell
41,262
-299
-0.7% -$2.53K 0.01% 1577
2021
Q3
$346K Sell
41,561
-5,526
-12% -$50.1K 0.01% 1675
2021
Q2
$480K Buy
47,087
+3,669
+8% +$35.6K 0.01% 1552
2021
Q1
$418K Sell
43,418
-2,113
-5% -$20.7K 0.01% 1525
2020
Q4
$477K Buy
45,531
+7,601
+20% +$60.3K 0.01% 1379
2020
Q3
$234K Sell
37,930
-13,631
-26% -$95.4K ﹤0.01% 1685
2020
Q2
$305K Sell
51,561
-1,883
-4% -$10.3K 0.01% 1532
2020
Q1
$283K Sell
53,444
-1,258
-2% -$8.63K 0.01% 1384
2019
Q4
$434K Sell
54,702
-1,428
-3% -$8.78K 0.01% 1417
2019
Q3
$306K Buy
56,130
+3,653
+7% +$16.1K 0.01% 1600
2019
Q2
$153K Buy
52,477
+5,171
+11% +$19.4K ﹤0.01% 2068
2019
Q1
$205K Buy
47,306
+131
+0.3% +$604 ﹤0.01% 1883
2018
Q4
$188K Hold
47,175
﹤0.01% 1862
2018
Q3
$344K Hold
47,175
0.01% 1638
2018
Q2
$468K Buy
47,175
+1,312
+3% +$13.6K 0.01% 1355
2018
Q1
$498K Buy
45,863
+2,949
+7% +$26.1K 0.01% 1277
2017
Q4
$272K Sell
42,914
-53,708
-56% -$409K ﹤0.01% 1705
2017
Q3
$857K Sell
96,622
-244
-0.3% -$2.35K 0.01% 1348
2017
Q2
$1.03M Hold
96,866
0.01% 1233
2017
Q1
$991K Buy
96,866
+2,480
+3% +$24.9K 0.01% 1238
2016
Q4
$801K Sell
94,386
-3,408
-3% -$29.2K 0.01% 1420
2016
Q3
$883K Sell
97,794
-1,761
-2% -$17K 0.01% 1356
2016
Q2
$1.12M Buy
99,555
+2,677
+3% +$35K 0.01% 1194
2016
Q1
$1.56M Buy
96,878
+5,076
+6% +$77.8K 0.01% 978
2015
Q4
$1.66M Hold
91,802
0.01% 961
2015
Q3
$1.8M Sell
91,802
-2,187
-2% -$47.7K 0.01% 951
2015
Q2
$1.97M Sell
93,989
-102
-0.1% -$2.07K 0.01% 973
2015
Q1
$1.85M Sell
94,091
-520
-0.5% -$8.74K 0.01% 913
2014
Q4
$1.39M Buy
94,611
+3,416
+4% +$45.2K 0.01% 1131
2014
Q3
$973K Sell
91,195
-8,032
-8% -$78.7K 0.01% 1291
2014
Q2
$913K Hold
99,227
0.01% 1414
2014
Q1
$901K Hold
99,227
0.01% 1421
2013
Q4
$970K Buy
99,227
+9,120
+10% +$90.6K 0.01% 1349
2013
Q3
$1.02M Sell
90,107
-8,414
-9% -$92.2K 0.01% 1271
2013
Q2
$1.05M Buy
+98,521
New +$879K 0.01% 1203

Other funds holding INFN

Metropolitan Life Insurance Company (MetLife)'s INFN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Infinera Corporation Common Stock (INFN) in Q2 2024, closing a stake of 9,108 shares — an estimated $54.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INFN in Q2 2013 and held it in 44 quarters. The position peaked at $1.97M in Q2 2015. 212 funds tracked by Wall St. Rank hold INFN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Infinera Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 9,108 Infinera Corporation Common Stock shares in Q2 2024, an estimated $54.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Infinera Corporation Common Stock in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Infinera Corporation Common Stock position peaked at $1.97M in Q2 2015.
  • 212 funds tracked by Wall St. Rank held Infinera Corporation Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.